It is the second leading cause of cancer deaths in the United States (approximately 56,000 deaths per year)
Colon Cancer does not discriminate, it affects people of all races and just as many women as it does men
Colorectal Cancer is the third most common cancer in the United States, yet the 2nd leading cause of cancer death.
The survival five year survival rate for people with early diagnosed colon cancer (Stage 1) is 98%
The five year survival rate for people with late diagnosed (Stage 4) colon cancer is 5%
Approximately 75% of people in the U.S. who develop cancer are 50 years or older with no other identifiable risk factors
Getting a colonoscopy can reduce the average person's risk of dying from colon cancer by 90%
At least 60% of Americans age 50 and older have never been screened for colon cancer
Greater than 50% of patients with colon cancer are diagnosed with advanced disease.
Colon Cancer deaths could be cut in half if everyone who was of age to be screened, actually got screened.
The Daniel L. Edelstein Fund is dedicated to improving the lives of those with colorectal cancer and ultimately eradicating the disease. We seek to promote community awareness and education while supporting innovative research to advance novel methods of early detection, prevention, and treatment. We recognize the beneficial role of nutrition, exercise and complementary medicine and seek to understand and organize their role in both comprehensive treatment plan and a lifestyle focused on prevention. By joining forces with the Johns Hopkins Colon Cancer Center, a global leader in healthcare, we are able to maximize positive changes for many people.
We are focused on supporting three key components of colon cancer:
Our goals include understanding the significant roles of Nutrition, Exercise, and Complementary Medicine in Colon Cancer Prevention and Treatment: